Biological tests showed profound anemia (Hb< 6g/dL), leucopenia, deep thrombocytopenia (platelet count <50,000 cells/mm3) and cytolysis respectively in 21.7%, 59.1%, 20.4% and 71.2%. This evidence concerns the gene GSTM1 and anemia (phenotype).